ALVO OAKTREE ACQUISITION CORP II

Transactions of Managers and Closely Associated Persons

Transactions of Managers and Closely Associated Persons

Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition of 19,988 shares in Alvotech at USD 10.18 per share, by Richard Davies, Deputy Chairman of the Board of Directors Alvotech. The transaction is dated May 14, 2025.

Attachment



EN
16/05/2025

Underlying

ALVOOAKTREE ACQUISITION CORP II

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OAKTREE ACQUISITION CORP II

 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech Announces the Outcome of the Offering in Connection with the ...

Alvotech Announces the Outcome of the Offering in Connection with the Company’s Listing on Nasdaq Stockholm Not to be released, published, distributed or circulated in any jurisdiction in which it would be unlawful to do so. This press release is for information purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. REYKJAVIK, ICELAND AND STOCKHOLM, SWEDEN (May 16, 2025) — Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today...

4h / 17m 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech tilkynnir niðurstöðu útboðs í tengslum við skráningu félagsin...

Alvotech tilkynnir niðurstöðu útboðs í tengslum við skráningu félagsins á Nasdaq markaðinn í Stokkhólmi Alvotech (NASDAQ: ALVO) tilkynnti í dag um niðurstöðu útboðs á sænskum heimildarskírteinum (SDR), sem eru ígildi hlutabréfa, í tengslum við væntanlega skráningu félagsins á Nasdaq markaðinn í Stokkhólmi. Sterkur áhugi var meðal almennra fjárfesta á útboðinu og var eftirspurn margföld á við framboð. Meira en 3.000 nýir hluthafar eignast nú hlut í Alvotech. Viðskipti með bréf Alvotech á Nasdaq markaðnum í Stokkhólmi hefjast mánudaginn 19. maí nk. undir auðkenninu „ALVO SDB“. Útboðið náði a...

4h / 17m 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Transactions of Managers and Closely Associated Persons

Transactions of Managers and Closely Associated Persons Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition of 19,988 shares in Alvotech at USD 10.18 per share, by Richard Davies, Deputy Chairman of the Board of Directors Alvotech. The transaction is dated May 14, 2025. Attachment

7h / 41m 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Viðskipti stjórnenda og tengdra aðila

Viðskipti stjórnenda og tengdra aðila Í viðhengi er tilkynning um viðskipti stjórnenda og tengdra aðila sem send var inn til fjármálaeftirlits Lúxemborgar, Luxembourg Commission de Surveillance du Secteur Financier (CSSF), varðandi kaup Richards Davies, varaformanns stjórnar Alvotech á 19.988 hlutum í Alvotech á genginu 10,18 Bandaríkjadalir á hlut. Viðskiptin eru dagsett miðvikudaginn 14. maí sl.  Viðhengi

7h / 41m 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Leiðrétting: Viðskipti stjórnenda og tengdra aðila

Leiðrétting: Viðskipti stjórnenda og tengdra aðila Í viðhengi er tilkynning um viðskipti stjórnenda og tengdra aðila sem lögð var inn til birtingar hjá fjármálaeftirliti Lúxemborgar, Luxembourg Commission de Surveillance du Secteur Financier (CSSF), um kaup Alvogen Lux Holdings S.ár.l. á 210,000 hlutum í Alvotech á genginu 1.277,38 krónur á hlut. Alvogen Lux Holdings er annar stærsti hluthafi Alvotech. Stærstu hluthafar Alvogen Lux Holdings eru fjárfestingasjóðirnir CVC (40%), Aztiq (30%) og Temasek (20%). (Leiðréttingin varðar fjölda keyptra hluta, sem voru sagðir 201,000 í upprunalegu ís...

May 13, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch